Back
Ascletis Pharma, Inc. Stock Predictions
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
77
ASCLF
Ascletis Pharma, Inc.
Last Price:
$1.7400
Seasonality Move:
285.53%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAscletis Pharma, Inc. Stock Forecast
-
Is Ascletis Pharma, Inc. Stock Undervalued?The current Ascletis Pharma, Inc. [ASCLF] share price is $1.7400. The Score for ASCLF is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
ASCLF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Ascletis Pharma, Inc. Stock Go Up Next Year?
Data Unavailable
Ascletis Pharma, Inc. Stock Rating
Data Unavailable
Ascletis Pharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
China
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascletis.com
52-Week Data
52-Week High:
1.9800
52-Week Low:
0.1753
Prediction Charts
Market Cap:
1.7B
Price in USD:
1.7400
Volume:
7K
Beta:
-12.5911
Technical Analysis
SMA50:
1.3675
SMA100:
1.4762
SMA200:
1.2060
52-Wk Change:
892.58%
Stock Predictions
-
Is Ascletis Pharma, Inc. stock public?Yes, Ascletis Pharma, Inc. is a publicly traded company.
-
What is the Ascletis Pharma, Inc. stock quote today?The Ascletis Pharma, Inc. stock price is 1.7400 USD today.
-
How to buy Ascletis Pharma, Inc. stock online?You can buy Ascletis Pharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 1.7750 | 1.7750 | 1.7750 | 1.7750 |
| Nov-18 | 1.7750 | 1.7750 | 1.7750 | 1.7750 |
| Nov-19 | 1.7750 | 1.7750 | 1.7750 | 1.7750 |
| Nov-20 | 1.7750 | 1.7750 | 1.7750 | 1.7750 |
| Nov-21 | 1.7750 | 1.7750 | 1.7750 | 1.7750 |
| Nov-24 | 1.7750 | 1.7750 | 1.7750 | 1.7750 |
| Nov-25 | 1.7750 | 1.7750 | 1.7750 | 1.7750 |
| Nov-26 | 1.7750 | 1.7750 | 1.7750 | 1.7750 |
| Nov-28 | 1.7750 | 1.7750 | 1.7750 | 1.7750 |
| Dec-1 | 1.7750 | 1.7750 | 1.7750 | 1.7750 |
| Dec-2 | 1.7800 | 1.7800 | 1.7800 | 1.7800 |
| Dec-3 | 1.4500 | 1.4500 | 1.4500 | 1.4500 |
| Dec-4 | 1.5800 | 1.5800 | 1.5800 | 1.5800 |
| Dec-5 | 1.7400 | 1.7400 | 1.7400 | 1.7400 |
Ascletis Pharma, Inc. Earnings
Data Unavailable
Ascletis Pharma, Inc. Forecast Revenue Growth
Data Unavailable
* Ascletis Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.